Patients presenting to the emergency department with apparent supraventricular tachycardia (SVT) need prompt follow-up with consideration for screening for atrial fibrillation (AF), especially those ...

MADISON, WI — The American College of Cardiology, American Heart Association, and the Heart Rhythm Society (ACC/AHA/HRS) have published new guidelines for the management of patients with ...

Untreated or unmanaged, SVT can lead to other possibly fatal heart abnormalities. Patients are advised to practice a cardiac-friendly diet and lifestyle (low sodium, little to no caffeine or alcohol, ...

Please provide your email address to receive an email when new articles are posted on . Patients with cancer and tachycardia had an increased risk for mortality near the time of treatment, according ...

Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

AOP Health US, LLC today announced that the U.S. Food and Drug Administration (FDA) has approved RAPIBLYK(R) (landiolol) for use in pediatric patients (from birth to <18 years of age) with ...

(HealthDay News) — For patients with symptomatic supraventricular tachycardia (SVT), caffeine is associated with increases in systolic and diastolic blood pressure, but does not impact cardiac ...

A recent study published in Pacing and Clinical Electrophysiology (PACE) determined that the use of catheter ablation to treat supraventricular tachycardia (SVT) is not detrimental to patients. This ...

(HealthDay News) — For patients with cancer, tachycardia can predict the risk for mortality, according to a study presented at the Advancing the Cardiovascular Care of the Oncology Patient conference ...

Patients with post-COVID-19 vaccination postural orthostatic tachycardia syndrome (POTS) all have preexisting conditions, according to a study published in the January issue of Heart Rhythm. Debbie ...

WILMINGTON, Del., April 15, 2026--(BUSINESS WIRE)--AOP Health US, LLC today announced that the U.S. Food and Drug Administration (FDA) has approved RAPIBLYK® (landiolol) for use in pediatric patients ...